Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease
Cardiovascular Diabetology
AUGUST 6, 2024
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry. vs. 6.8%), myocardial infarction (7.7%
Let's personalize your content